{"id":8527,"date":"2026-05-08T22:39:48","date_gmt":"2026-05-08T19:39:48","guid":{"rendered":"https:\/\/dbsnewsmedia.com\/?p=8527"},"modified":"2026-05-08T22:40:10","modified_gmt":"2026-05-08T19:40:10","slug":"pandeminin-yildizi-biontechte-dusus-tesisler-kapaniyor-ayriliklar-artiyor","status":"publish","type":"post","link":"https:\/\/dbsnewsmedia.com\/?p=8527","title":{"rendered":"PANDEM\u0130N\u0130N YILDIZI BIONTECH\u2019TE D\u00dc\u015e\u00dc\u015e: TES\u0130SLER KAPANIYOR, AYRILIKLAR ARTIYOR"},"content":{"rendered":"\n

COVID-19 a\u015f\u0131s\u0131yla k\u00fcresel ba\u015far\u0131 elde eden BioNTech, pandemi sonras\u0131 talep d\u00fc\u015f\u00fc\u015f\u00fc ve finansal kay\u0131plar nedeniyle yeniden yap\u0131lanmaya gidiyor. \u015eirket, \u00fcretim tesislerini kapat\u0131rken kurucular U\u011fur \u015eahin ve \u00d6zlem T\u00fcreci de g\u00f6revlerinden ayr\u0131lmaya haz\u0131rlan\u0131yor.<\/a><\/p>\n\n\n\n

\n\n\n\n

COVID-19 pandemisi s\u0131ras\u0131nda geli\u015ftirdi\u011fi mRNA a\u015f\u0131s\u0131yla k\u00fcresel \u00f6l\u00e7ekte \u201cpandeminin kahramanlar\u0131\u201d olarak an\u0131lan BioNTech, bug\u00fcn ciddi bir yeniden yap\u0131lanma s\u00fcrecinden ge\u00e7iyor. \u015eirket, Sal\u0131 g\u00fcn\u00fc yapt\u0131\u011f\u0131 a\u00e7\u0131klamada Almanya ve Singapur\u2019daki baz\u0131 \u00fcretim tesislerini kapataca\u011f\u0131n\u0131 ve maliyetleri d\u00fc\u015f\u00fcrme program\u0131 ba\u015flatt\u0131\u011f\u0131n\u0131 duyurdu.<\/p>\n\n\n\n

Deutsche Welle\u2019nin aktard\u0131\u011f\u0131 a\u00e7\u0131klamaya g\u00f6re, son \u00e7eyrekte 532 milyon euroluk net zarar a\u00e7\u0131klayan \u015firket, yakla\u015f\u0131k 1.860 \u00e7al\u0131\u015fan\u0131n i\u015finin risk alt\u0131nda oldu\u011funu bildirdi. BioNTech, ayn\u0131 zamanda COVID-19 a\u015f\u0131s\u0131 \u00fcretimini b\u00fcy\u00fck \u00f6l\u00e7\u00fcde orta\u011f\u0131 Pfizer\u2019a devretme karar\u0131 ald\u0131.<\/p>\n\n\n\n

A\u015eI SATI\u015eLARINDA GER\u0130LEME<\/h2>\n\n\n\n

Bir d\u00f6nem milyarlarca doz a\u015f\u0131 \u00fcreterek pandeminin seyrini de\u011fi\u015ftiren ve k\u00fcresel ekonomilerin yeniden a\u00e7\u0131lmas\u0131nda kritik rol oynayan \u015firket, bug\u00fcn COVID-19 a\u015f\u0131lar\u0131na olan talebin h\u0131zl\u0131 d\u00fc\u015f\u00fc\u015f\u00fc nedeniyle ciddi gelir kayb\u0131 ya\u015f\u0131yor. 2026\u2019n\u0131n ilk \u00e7eyre\u011finde gelirlerin ge\u00e7en y\u0131l\u0131n ayn\u0131 d\u00f6nemine g\u00f6re y\u00fczde 35 d\u00fc\u015ferek 118 milyon euroya geriledi\u011fi belirtildi.<\/p>\n\n\n\n

Finansal analistlere g\u00f6re BioNTech\u2019in mevcut krizi, pandemi d\u00f6neminde elde edilen ola\u011fan\u00fcst\u00fc gelirin ge\u00e7ici olmas\u0131ndan kaynaklan\u0131yor. \u015eirketin y\u00fcksek \u00fcretim kapasitesini pandemi sonras\u0131 talep daralmas\u0131na g\u00f6re k\u00fc\u00e7\u00fcltememesi ise at\u0131l tesisler ve artan maliyetler sorununu beraberinde getirdi.<\/p>\n\n\n\n

BIONTECH\u2019TEN STRATEJ\u0130K SATIN ALMA HAMLES\u0130<\/h2>\n\n\n\n

\u015eirket ayr\u0131ca ge\u00e7en y\u0131l rakibi CureVac\u2019\u0131 sat\u0131n almas\u0131yla da tart\u0131\u015fma konusu oldu. Bu ad\u0131m\u0131n hem patent anla\u015fmazl\u0131klar\u0131n\u0131 sonland\u0131rmak hem de olas\u0131 hukuki riskleri azaltmak amac\u0131 ta\u015f\u0131d\u0131\u011f\u0131 belirtilse de, yerel y\u00f6neticiler ve sendikalar bu durumu \u201c\u00f6nce sat\u0131n al, sonra kapat\u201d ele\u015ftirileriyle de\u011ferlendirdi.<\/p>\n\n\n\n

BioNTech\u2019in yeniden yap\u0131lanma s\u00fcrecinde en dikkat \u00e7ekici geli\u015fmelerden biri de kurucular U\u011fur \u015eahin ve \u00d6zlem T\u00fcreci\u2019nin g\u00f6revlerinden ayr\u0131laca\u011f\u0131n\u0131 a\u00e7\u0131klamas\u0131 oldu. Bu ayr\u0131l\u0131k sonras\u0131 \u015firket hisselerinde yakla\u015f\u0131k y\u00fczde 18\u2019lik de\u011fer kayb\u0131 ya\u015fand\u0131\u011f\u0131 ifade edildi.<\/p>\n\n\n\n

YEN\u0130 D\u00d6NEM\u0130N MERKEZ\u0130NDE mRNA \u00c7ALI\u015eMALARI<\/strong><\/h2>\n\n\n\n

\u015eirket y\u00f6netimi, stratejik oda\u011f\u0131n\u0131 COVID-19 a\u015f\u0131lar\u0131ndan \u00e7\u0131kararak kanser tedavilerine y\u00f6nelik mRNA tabanl\u0131 ara\u015ft\u0131rmalara kayd\u0131rmay\u0131 planl\u0131yor. Bu kapsamda meme ve akci\u011fer kanseri ba\u015fta olmak \u00fczere \u00e7e\u015fitli alanlarda 15 Faz 3 klinik \u00e7al\u0131\u015fman\u0131n y\u00fcr\u00fct\u00fcld\u00fc\u011f\u00fc a\u00e7\u0131kland\u0131.<\/p>\n\n\n\n

BioNTech, 2029\u2019a kadar y\u0131ll\u0131k yakla\u015f\u0131k 500 milyon euro tasarruf hedeflerken, gelecekte mRNA teknolojisini onkoloji alan\u0131nda ticari ba\u015far\u0131ya d\u00f6n\u00fc\u015ft\u00fcrmeyi ama\u00e7l\u0131yor. Kurucular\u0131n ayr\u0131l\u0131\u011f\u0131 sonras\u0131 \u015firketin inovasyon kapasitesini s\u00fcrd\u00fcrebilip s\u00fcrd\u00fcremeyece\u011fi ise sekt\u00f6r i\u00e7inde en kritik soru ba\u015fl\u0131\u011f\u0131 olarak \u00f6ne \u00e7\u0131k\u0131yor.<\/p>\n\n\n\n

08.05.2026,22.40<\/p>\n\n\n\n

Kom\u015fu Haber:https:\/\/opennewsmedia.com\/2026\/05\/08\/pandeminin-yildizi-biontechte-dusus-tesisler-kapaniyor-ayriliklar-artiyor\/<\/a><\/p>\n\n\n\n

Kaynak: https:\/\/gazeteoksijen.com\/dunya\/ture-ve-sahin-ayriliyor-tesisler-kapaniyor-pandemi-kahramani-biontech-nasil-dususe-gecti-274850<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

COVID-19 a\u015f\u0131s\u0131yla k\u00fcresel ba\u015far\u0131 elde eden BioNTech, pandemi sonras\u0131 talep d\u00fc\u015f\u00fc\u015f\u00fc ve finansal kay\u0131plar nedeniyle yeniden yap\u0131lanmaya gidiyor. \u015eirket, \u00fcretim tesislerini kapat\u0131rken kurucular U\u011fur \u015eahin ve \u00d6zlem T\u00fcreci de g\u00f6revlerinden ayr\u0131lmaya haz\u0131rlan\u0131yor. COVID-19 pandemisi s\u0131ras\u0131nda geli\u015ftirdi\u011fi mRNA a\u015f\u0131s\u0131yla k\u00fcresel \u00f6l\u00e7ekte \u201cpandeminin kahramanlar\u0131\u201d olarak an\u0131lan BioNTech, bug\u00fcn ciddi bir yeniden yap\u0131lanma s\u00fcrecinden ge\u00e7iyor. \u015eirket, Sal\u0131 g\u00fcn\u00fc…<\/p>\n","protected":false},"author":3,"featured_media":8528,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[3],"tags":[314],"class_list":["post-8527","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-dunya","tag-dunya-2"],"jetpack_featured_media_url":"https:\/\/dbsnewsmedia.com\/wp-content\/uploads\/2026\/05\/almanyada-biontech-davasinin-ilk-durusmasi-iptal-edildi-Mey7.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/dbsnewsmedia.com\/index.php?rest_route=\/wp\/v2\/posts\/8527","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dbsnewsmedia.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dbsnewsmedia.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dbsnewsmedia.com\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/dbsnewsmedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=8527"}],"version-history":[{"count":2,"href":"https:\/\/dbsnewsmedia.com\/index.php?rest_route=\/wp\/v2\/posts\/8527\/revisions"}],"predecessor-version":[{"id":8531,"href":"https:\/\/dbsnewsmedia.com\/index.php?rest_route=\/wp\/v2\/posts\/8527\/revisions\/8531"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dbsnewsmedia.com\/index.php?rest_route=\/wp\/v2\/media\/8528"}],"wp:attachment":[{"href":"https:\/\/dbsnewsmedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=8527"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dbsnewsmedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=8527"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dbsnewsmedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=8527"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}